Status:
COMPLETED
Development of a Mobile App for an Executive Functioning Intervention for Adolescents
Lead Sponsor:
University of California, San Francisco
Conditions:
Attention Deficit Hyperactivity Disorder Symptoms
Eligibility:
All Genders
11-15 years
Phase:
NA
Brief Summary
This study develops an initial prototype of a mobile tool that will support clinician-directed behavioral/organizational skills treatment for adolescents with Attention Deficit Hyperactivity Disorder ...
Detailed Description
Attention-Deficit/Hyperactivity Disorder (ADHD) is one of the most common childhood mental health disorders, affecting 7-9% of children and adolescents, and leading to substantial impairment in adoles...
Eligibility Criteria
Inclusion
- 1\) Youth ages of 11-14 years (6-8th grade) that are attending a participating school
- 2\) referred by SMHP as a youth with apparent ADHD-related problems,
- 3\) ≥6 symptoms (item score ≥2) of Inattention or Hyperactivity-Impulsivity on the pooled parent and teacher Vanderbilt ADHD Rating Scale
- 4\) ≥3 on the Impairment Rating Scale by parent and teacher (cross-situational impairment)
- 5\) Parent consent and adolescent assent must be provided; b)
Exclusion
- 1\) No presence of conditions that are incompatible with this study's treatment including: Parent or adolescent report of a prior diagnosis of either Autism Spectrum Disorder, Bipolar Disorder, a Dissociative Disorder, Severe visual or hearing impairment, severe language delay or intellectual impairment, or a Psychotic Disorder will be excluded. Rationale: Individuals with these disorders often have very dysregulated behavior and impairments that deviate from the focus of this study.
- 2\) Adolescent is in all-day special education classes or if core classes not in regular education classrooms. Rationale: The vast majority of adolescent with ADHD are served in regular education classrooms and students in full-day self-contained classrooms often have different challenges than students in regular education.
- 3\) Adolescent planning to change (start or stop) psychotropic medication. Note: Adolescents taking medication will be required to meet all entry criteria, including impairment criteria, thus indicating a need for the intervention. Adolescent taking medication for attention or behavior are eligible as long as their medication regimens are stable. Participating parents will also need to be able to read/speak English because all measures are in English, and the intervention will be conducted in English.
Key Trial Info
Start Date :
September 30 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2020
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04018794
Start Date
September 30 2019
End Date
September 1 2020
Last Update
November 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94143